文献速递多重用药老年综合评估老年慢病共病管理

老年人不适当处方:危害与对策

Inappropriate prescribing: hazards and solutions.
PubMed 文献 · Age Ageing · 2022-01-01

本文为评论性文章,讨论老龄化背景下多病共存与多重用药导致药物相关问题和不适当处方的机制与后果。文章提出通过药物重整、识别标准、计算机处方系统和老年综合评估来优化处方,强调个体化、多学科综合管理。

要点

  • 老年人因药代与药效动力学变化易发生药物相关问题,多重用药可致处方瀑布与药物相互作用。
  • 识别与预防不适当处方需结合药物重整、相关标准、计算机处方系统及老年综合评估。
  • 合适处方需权衡预期获益与风险,个体化多学科综合管理应被推广。

核心结论

  • 晚年良好处方应满足多病共存老年患者的需求,应推广个体化、互动、多学科和多层面的老年药物治疗方法。

研究设计与样本

  • 本文为评论性文章,讨论老年人药物相关问题和不适当处方的易感性、后果及优化策略。

主要发现

  • 老年人因药代动力学和药效动力学变化而易发生药物相关问题。
  • 多重用药可导致处方瀑布、药物相互作用和潜在不适当处方。
  • 识别药物相关问题与优化不适当处方包括药物重整、应用识别与预防标准、实施计算机处方系统及老年综合评估与管理。

临床怎么用

  • 通过老年综合评估在多病共存、脆弱性增加和预期寿命有限的情况下做出知情处方决策。
  • 采用个体化、互动、多学科和多层面的方法优化老年药物治疗。

局限性

  • 未来研究挑战在于如何将现有方法获得的重要临床信息整合为全面广泛的方法,以覆盖导致药物相关问题的所有潜在因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With population ageing, the number of older people is growing, which results in increasing number of people with multimorbidity and related polypharmacy. Polypharmacy in its turn leads to drug-related problems (DRPs) and potentially inappropriate prescribing (IP) in older people. In this commentary, susceptibility of older people to DRPs due to changes in pharmacokinetics and pharmacodynamics, plurality of prescribing physicians, inadequate consideration of patients' characteristics, polypharmacy and its consequences such as prescribing cascades, drug interactions and potentially IP have been discussed respectively. Consecutively, identifying DRPs and optimizing of IP, including drug reconciliation, application of criteria for identifying and preventing IP, implementation of computer-based prescribing systems, and comprehensive geriatric assessment and management have been elaborated as well. One of the main challenges regarding appropriate and tailored prescribing in older people is to evaluate whether the expected benefits of pharmacotherapy are bigger than the risks in a population with multimorbidity, decreased tolerance to vulnerability and limited life expectancy. Comprehensive geriatric assessment enables informed prescribing decisions in the context of such variables. A challenge for future research is how to integrate important clinical information obtained by existing methods into a comprehensive and wide-reaching approach targeting all potential factors involved in causing DRPs. Good prescribing in late life accommodates the needs of older patients with multimorbidity. Individualized, interactive, multidisciplinary, and multifaceted approach to geriatric pharmacotherapy should be promoted and encouraged. How to optimize pharmacological prescription in complex older patients is a major legacy of geriatrics to contemporary medicine/medical practice.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Petrovic M, O'Mahony D, Cherubini A, et al. Inappropriate prescribing: hazards and solutions. Age Ageing. 2022. PMID: 35136899. doi:10.1093/ageing/afab269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。